RNA干扰技术治疗肝癌的作用机制

摘要/Abstract

摘要：原发性肝癌是常见的恶性肿瘤之一，但是传统的治疗手段疗效并不令人满意。RNA干扰是近年来发展较快的新的治疗手段，研究发现它能够通过抑制肝癌细胞生长、增殖和促进细胞凋亡，抑制肝癌细胞侵袭和转移，抑制肿瘤新生血管生成和克服化疗耐药的途径发挥抗肿瘤作用。

侯晓芸,褚燕君. RNA干扰技术治疗肝癌的作用机制[J]. 国际肿瘤学杂志, 2017, 44(4): 297-299.

Hou Xiaoyun, Chu Yanjun.. The mechanism of RNA interference for hepatocellular carcinoma treatment[J]. Journal of International Oncology, 2017, 44(4): 297-299.

［1］ Jemal A, Bray F, Center MM, et al. Global cancer statistics［J］. CA Cancer J Clin, 2011, 61(2): 69-90. DOI: 10.3322/caac.20107. ［2］ Li L, Mu-oz-Culla M, Carmona U, et al. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells［J］. Biomaterials, 2016, 98: 143-151. DOI: 10.1016/j.biomaterials.2016.05.006. ［3］ PalancaWessels MC, Booth GC, Convertine AJ, et al. Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2overexpressing cancer cells［J］. Oncotarget, 2016, 7(8): 9561-9575. DOI: 10.18632/oncotarget.7076. ［4］ Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation［J］. Science, 2009, 324(5930): 1029-1033. DOI: 10.1126/science.1160809. ［5］ Noguchi C, Kamitori K, Hossain A, et al. D-allose inhibits cancer cell growth by reducing GLUT1 expression［J］. Tohoku J Exp Med, 2016, 238(2): 131-141. DOI: 10.1620/tjem.238.131. ［6］ Huang Q, Li J, Xing J, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53dependent signaling pathway［J］. J Hepatol, 2014, 61(4): 859-866. DOI: 10.1016/j.jhep.2014.04.035. ［7］ Amann T, Maegdefrau U, Hartmann A, et al. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis［J］. Am J Pathol, 2009, 174(4): 1544-1552. DOI: 10.2353/ajpath.2009.080596. ［8］ Cho-Rok J, Yoo J, Jang YJ, et al. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo［J］. Hepatology, 2006, 43(5): 1042-1052. ［9］ Doan CC, Doan NT, Nguyen QH, et al. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells［J］. Iran Biomed J, 2015, 19(1): 1-16. ［10］ Liu W, Zhu F, Jiang Y, et al. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells［J］. Oncol Rep, 2013, 29(3): 1183-1188. DOI: 10.3892/or.2012.2196. ［11］ Vogl TJ, Oppermann E, Qian J, et al. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol［J］. BMC Cancer, 2016, 16: 325. DOI: 10.1186/s12885-016-2357-3. ［12］ Zhao A, Zeng Q, Xie X, et al. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression［J］. J Genet Genomics, 2012, 39(1): 29-35. DOI: 10.1016/j.jgg.2011.12.003. ［13］ Fu BH, Wu ZZ, Qin J. Effects of integrin α6β1 on migration of hepatocellular carcinoma cells［J］. Mol Biol Rep, 2011, 38(5): 3271-3276. DOI: 10.1007/s11033-0100308-7. ［14］ Lv G, Lv T, Qiao S, et al. RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells［J］. Eur J Med Res, 2013, 18: 52. DOI: 10.1186/2047-783X-18-52. ［15］ Wu JM, Xu Y, Skill NJ, et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma［J］. Mol Cancer, 2010, 9: 71. DOI: 10.1186/1476-4598-9-71. ［16］ BenBaruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors［J］. Clin Exp Metastasis, 2008, 25(4): 345-356. DOI: 10.1007/s10585-007-9097-3. ［17］ Xue TC, Chen RX, Han D, et al. Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential［J］. Exp Ther Med, 2012, 3(1): 117-123. ［18］ Lu Y, Zhu M, Li W, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells［J］. J Cell Mol Med, 2016, 20(3): 549-558. DOI: 10.1111/jcmm.12745. ［19］ Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets［J］. Nat Med, 2011, 17(11): 1359-1370. DOI: 10.1038/nm.2537. ［20］ Chen S, Feng J, Ma L, et al. RNA interference technology for anti-VEGF treatment［J］. Expert Opin Drug Deliv, 2014, 11(9): 1471-1480. DOI: 10.1517/17425247.2014.926886. ［21］ Zou Y, Guo CG, Zhang MM. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion［J］. Eur Rev Med Pharmacol Sci, 2015, 19(24): 4751-4761. ［22］ Hague S, Zhang L, Oehler MK, et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density［J］. Clin Cancer Res, 2000, 6(7): 2808-2814. ［23］ Li F, Yang R, Zhang X, et al. Silencing of hypoxia-inducible adrenomedullin using RNA interference attenuates hepatocellular carcinoma cell growth in vivo［J］. Mol Med Rep, 2014, 10(3): 1295-1302. DOI: 10.3892/mmr.2014.2320. ［24］ Meng W, Li X, Bai Z, et al. Silencing alphafetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell［J］. PLoS One, 2014, 9(2): e90660. DOI: 10.1371/journal.pone.0090660. ［25］ Yang T, Zheng ZM, Li XN, et al. MiR-223modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells［J］. Exp Biol Med (Maywood), 2013, 238(9): 1024-1032. DOI: 10.1177/1535370213497321. ［26］ Su Z, Liu G, Fang T, et al. Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy［J］. Am J Transl Res, 2016, 8(6): 2790-2802. ［27］ Tang B, Hu Z, Li Y, et al. Downregulation of δ opioidreceptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU［J］. Mol Med Rep, 2016, 13(1): 59-66. DOI: 10.3892/mmr.2015.4511.

[1]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[2]	任露, 谢晓丽, 张坤, 王丽娟.双氢青蒿素联合卡非佐米对多发性骨髓瘤细胞活性、增殖、凋亡的影响及机制研究[J]. 国际肿瘤学杂志, 2024, 51(3): 129-136.
[3]	彭琴, 蔡玉婷, 王伟.KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	张科平, 赵永生, 杨娟, 付茂勇.绿原酸通过抑制PI3K-Akt信号通路诱导肺癌A549细胞线粒体功能障碍[J]. 国际肿瘤学杂志, 2024, 51(1): 21-28.
[6]	向玉玲, 谭佳杰, 熊远果, 赵丽蓉, 黎晨, 张洪.脱水淫羊藿素对肝癌细胞增殖、迁移和凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(9): 513-519.
[7]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[8]	吴佳丽, 张佳慧, 张萍, 肖昕悦, 李睿, 张红宇.Bcl-2 BH4选择性抑制剂BDA-366抑制NK/T细胞淋巴瘤细胞的机制研究[J]. 国际肿瘤学杂志, 2023, 50(7): 413-418.
[9]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平.GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[10]	李佳璇, 封颖璐.糖皮质激素受体在肝癌细胞生长中的作用机制[J]. 国际肿瘤学杂志, 2023, 50(4): 241-243.
[11]	朱易, 陈健.硫化氢在肿瘤发生发展中的作用机制及其供体抗肿瘤作用[J]. 国际肿瘤学杂志, 2023, 50(12): 729-733.
[12]	和婷, 王希, 张惠中, 刘昕阳, 王会平, 董轲.血清TIM-3对肝癌患者诊断价值的研究[J]. 国际肿瘤学杂志, 2022, 49(9): 537-542.
[13]	连海伟, 杨烁锐, 刘仁忠.金松双黄酮联合CX-4945通过Notch1通路调控胶质母细胞瘤细胞增殖与凋亡的机制研究[J]. 国际肿瘤学杂志, 2022, 49(6): 321-326.
[14]	杨娅, 宁晓飞, 李炳亮, 姚慧, 山长平, 吕敏.原花青素通过诱导活性氧产生介导抗SNU-1胃癌细胞株的作用机制研究[J]. 国际肿瘤学杂志, 2022, 49(5): 257-262.
[15]	张玉敏, 赵现伟, 何前进, 陈杰能.超声造影联合血清CXCL8、CXCR2在原发性肝癌经导管动脉化疗栓塞术后疗效评估中的价值分析[J]. 国际肿瘤学杂志, 2022, 49(10): 592-596.

RNA干扰技术治疗肝癌的作用机制

The mechanism of RNA interference for hepatocellular carcinoma treatment

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价